Evolutionary Genomics, Inc. Pre-Tax Income
Evolutionary Genomics, Inc. reported Pre-Tax Income of -$1.93 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2023-03-09
- Evolutionary Genomics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-12-31 was -$333.75K.
- Evolutionary Genomics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-09-30 was -$545.28K.
- Evolutionary Genomics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-06-30 was -$531.07K.
- Evolutionary Genomics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-03-31 was -$524.87K.
- Evolutionary Genomics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$1.93M.
- Evolutionary Genomics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2021 was -$2.79M.
- Evolutionary Genomics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2020 was -$2.70M.
- Evolutionary Genomics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2019 was -$761.23K.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$333.75K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$879.03K derived: sum of 2 quarters · filed 2023-03-09 | -$1.41M derived: sum of 3 quarters · filed 2023-03-09 | -$1.93M 10-K · filed 2023-03-09 |
| 2022-09-30 | -$545.28K 10-Q · filed 2022-10-21 | -$1.08M derived: sum of 2 quarters · filed 2022-10-21 | -$1.60M 10-Q · filed 2022-10-21 | -$2.27M derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-06-30 | -$531.07K 10-Q · filed 2022-08-08 | -$1.06M 10-Q · filed 2022-08-08 | -$1.72M derived: sum of 3 quarters · filed 2023-03-09 | -$2.78M derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-03-31 | -$524.87K 10-Q · filed 2022-05-16 | -$1.19M derived: sum of 2 quarters · filed 2023-03-09 | -$2.25M derived: sum of 3 quarters · filed 2023-03-09 | -$2.81M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-12-31 | -$667.84K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$1.73M derived: sum of 2 quarters · filed 2023-03-09 | -$2.28M derived: sum of 3 quarters · filed 2023-03-09 | -$2.79M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$1.06M 10-Q · filed 2022-10-21 | -$1.61M derived: sum of 2 quarters · filed 2022-10-21 | -$2.13M 10-Q · filed 2022-10-21 | -$3.84M derived: sum of 4 quarters · filed 2022-10-21 |
| 2021-06-30 | -$553.70K 10-Q · filed 2022-08-08 | -$1.07M 10-Q · filed 2022-08-08 | -$2.78M derived: sum of 3 quarters · filed 2022-08-08 | -$3.23M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$513.74K 10-Q · filed 2022-05-16 | -$2.22M derived: sum of 2 quarters · filed 2022-05-16 | -$2.68M derived: sum of 3 quarters · filed 2022-05-16 | -$2.97M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$2.16M derived: sum of 2 quarters · filed 2022-03-22 | -$2.46M derived: sum of 3 quarters · filed 2022-03-22 | -$2.70M 10-K · filed 2022-03-22 |
| 2020-09-30 | -$451.47K 10-Q · filed 2021-11-01 | -$746.27K derived: sum of 2 quarters · filed 2021-11-01 | -$988.08K 10-Q · filed 2021-11-01 | -$1.21M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | -$294.80K 10-Q · filed 2021-08-06 | -$536.61K 10-Q · filed 2021-08-06 | -$759.38K derived: sum of 3 quarters · filed 2021-08-06 | -$915.71K derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | -$241.82K 10-Q · filed 2021-05-13 | -$464.59K derived: sum of 2 quarters · filed 2021-05-13 | -$620.91K derived: sum of 3 quarters · filed 2021-05-13 | -$802.65K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$222.77K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$379.09K derived: sum of 2 quarters · filed 2021-03-31 | -$560.84K derived: sum of 3 quarters · filed 2021-03-31 | -$761.23K 10-K · filed 2021-03-31 |
| 2019-09-30 | -$156.32K 10-Q · filed 2020-11-13 | -$338.07K derived: sum of 2 quarters · filed 2020-11-13 | -$538.46K 10-Q · filed 2020-11-13 | |
| 2019-06-30 | -$181.75K 10-Q · filed 2020-08-19 | -$382.14K 10-Q · filed 2020-08-19 | ||
| 2019-03-31 | -$200.40K 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | -$1.10M 10-K · filed 2020-03-30 | |||
| 2017-12-31 | -$1.07M 10-K · filed 2019-04-01 | |||
| 2016-12-31 | -$1.15M 10-K · filed 2018-03-05 |